Gene · 3428
Papers2,876
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,876
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulatory Cues in Pulmonary Fibrosis-With Emphasis on the AIM2 Inflammasome. | Int J Mol Sci | 2023 | 37446052 | PubTator, text mining | PubMed |
| The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment. | Int J Mol Sci | 2023 | 37445915 | PubTator, text mining | PubMed |
| Transcriptomic Analysis Reveals the Inability of Recombinant AAV8 to Activate Human Monocyte-Derived Dendritic Cells. | Int J Mol Sci | 2023 | 37445621 | PubTator, text mining | PubMed |
| Spatial immunophenotypes orchestrate prognosis in triple-negative breast cancer with Miller-Payne grade 4 following neoadjuvant chemotherapy. | NPJ Breast Cancer | 2023 | 37438419 | PubTator, text mining | PubMed |
| Deep learning identifies a T-cell exhaustion-dependent transcriptional signature for predicting clinical outcomes and response to immune checkpoint blockade. | Oncogenesis | 2023 | 37433793 | PubTator, text mining | PubMed |
| Autoinflammatory diseases: what is behind them and what is new? | Dermatol Reports | 2023 | 37426375 | PubTator, text mining | PubMed |
| Advanced methods and novel biomarkers in autoimmune diseases ‑ a review of the recent years progress in systemic lupus erythematosus. | Front Med (Lausanne) | 2023 | 37425332 | PubTator, text mining | PubMed |
| Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity. | Front Cell Infect Microbiol | 2023 | 37424786 | PubTator, text mining | PubMed |
| Elevated glutamate impedes anti-HIV-1 CD8 + T cell responses in HIV-1-infected individuals on antiretroviral therapy. | Commun Biol | 2023 | 37419968 | PubTator, text mining | PubMed |
| Restoring tumor immunogenicity with dendritic cell reprogramming. | Sci Immunol | 2023 | 37418548 | PubTator, text mining | PubMed |
| USP12 promotes antiviral responses by deubiquitinating and stabilizing IFI16. | PLoS Pathog | 2023 | 37410794 | PubTator, text mining | PubMed |
| HPV18 E6 inhibits α-ketoglutarate-induced pyroptosis of esophageal squamous cell carcinoma cells via the P53/MDH1/ROS/GSDMC pathway. | FEBS Open Bio | 2023 | 37402485 | PubTator, text mining | PubMed |
| Molecular and cellular pathophysiology of circulating cardiomyocyte-specific cell free DNA (cfDNA): Biomarkers of heart failure and potential therapeutic targets. | Genes Dis | 2023 | 37396513 | PubTator, text mining | PubMed |
| Renal interferon-inducible protein 16 expression is associated with disease activity and prognosis in lupus nephritis. | Arthritis Res Ther | 2023 | 37393341 | PubTator, text mining | PubMed |
| Systems crosstalk between antiviral response and cancerous pathways via extracellular vesicles in HIV-1-associated colorectal cancer. | Comput Struct Biotechnol J | 2023 | 37389186 | PubTator, text mining | PubMed |
| Mechanistic rationales for combining immunotherapy with radiotherapy. | Front Immunol | 2023 | 37377970 | PubTator, text mining | PubMed |
| NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances. | Pharmaceuticals (Basel) | 2023 | 37375731 | PubTator, text mining | PubMed |
| The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma. | Int J Mol Sci | 2023 | 37373484 | PubTator, text mining | PubMed |
| Immunomodulatory Role of Interferons in Viral and Bacterial Infections. | Int J Mol Sci | 2023 | 37373262 | PubTator, text mining | PubMed |
| Inhibition of AIM2 inflammasome activation by SOX/ORF37 promotes lytic replication of Kaposi's sarcoma-associated herpesvirus. | Proc Natl Acad Sci U S A | 2023 | 37364111 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3428/papers?page=17